Rajkumar, S., Greipp, P. R., Jacobus, S., Callander, N. S., Fonseca, R., Vesole, D., . . . Katz, M. (2009). Lenalidomide plus high-dose dexamethasone versus lenalidomide plus low-dose dexamethasone as initial therapy for newly diagnosed multiple myeloma: An open-label randomised controlled trial.
Dyfyniad Arddull ChicagoRajkumar, SV, et al. Lenalidomide Plus High-dose Dexamethasone Versus Lenalidomide Plus Low-dose Dexamethasone As Initial Therapy for Newly Diagnosed Multiple Myeloma: An Open-label Randomised Controlled Trial. 2009.
Dyfyniad MLARajkumar, SV, et al. Lenalidomide Plus High-dose Dexamethasone Versus Lenalidomide Plus Low-dose Dexamethasone As Initial Therapy for Newly Diagnosed Multiple Myeloma: An Open-label Randomised Controlled Trial. 2009.